The future of the generics landscape

Clarivate analysts have identified six brands losing exclusivity in 2021 and beyond that could impact the generics market. They also flagged antineoplastics therapeutic area, which has several brands expected to lose exclusivity in the next five years.

Download the report
Drugs to Watch
Drugs to Watch
Drugs to Watch
Drugs to Watch

From innovation to bottom line

Access our global intelligence, advanced analytics and global team of experts.

Contact our team